Evidence map›Paper›PMID 30327430›Full record

ArticleThe Journal of biological chemistry2018

Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51.

Tatiana Y Hargrove, Zdzislaw Wawrzak, Paxtyn M Fisher, Stella A Child, W David Nes, F Peter Guengerich, Michael R Waterman, Galina I Lepesheva

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of Potent and Selective Inhibitors ofJournal of medicinal chemistry · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Structural Insights into the Azole Resistance of theJournal of fungi (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tatiana Y HargroveFrom the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Zdzislaw WawrzakSynchrotron Research Center, Life Science Collaborative Access Team, Northwestern University, Argonne, Illinois 60439.
Paxtyn M Fisherthe Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, and.
Stella A ChildFrom the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.ORCID 0000-0002-7130-9676
W David Nesthe Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, and.
F Peter GuengerichFrom the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.ORCID 0000-0002-7458-3048
Michael R WatermanFrom the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Galina I LepeshevaFrom the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, galina.i.lepesheva@vanderbilt.edu.ORCID 0000-0002-6975-1131
Vanderbilt University · USTexas Tech University · USNorthwestern University · US

Funding

Structural Requirements for Sterol 14alpha-DemethylasesR01GM067871 · NIGMS · VANDERBILT UNIVERSITY · PI LEPESHEVA, GALINA I · 2004 to 2023
$7.2M
Discovery of New Anti-amoeba TherapeuticsR33AI119782 · NIAID · TEXAS TECH UNIVERSITY · PI NES, WILLIAM DAVID · 2017 to 2019
$881k
NIAID NIH HHS R33 AI119782NIGMS NIH HHS R01 GM067871
6 · The paper itself

Abstract

Sterol 14α-demethylases (CYP51s) are phylogenetically the most conserved cytochromes P450, and their three-step reaction is crucial for biosynthesis of sterols and serves as a leading target for clinical and agricultural antifungal agents. The structures of several (bacterial, protozoan, fungal, and human) CYP51 orthologs, in both the ligand-free and inhibitor-bound forms, have been determined and have revealed striking similarity at the secondary and tertiary structural levels, despite having low sequence identity. Moreover, in contrast to many of the substrate-promiscuous, drug-metabolizing P450s, CYP51 structures do not display substantial rearrangements in their backbones upon binding of various inhibitory ligands, essentially representing a snapshot of the ligand-free sterol 14α-demethylase. Here, using the obtusifoliol-bound I105F variant of

Indexed as

BiocatalysisElectron TransportEnzyme StabilityHemeModels, MolecularProtein BindingProtein ConformationSterol 14-DemethylaseTrypanosoma cruziHemeSterol 14-Demethylasecatalysisconformational changecytochrome P450druggabilitydrug targetsterol 14alpha-demethylase (CYP51)sterol biosynthesisstructure-functionsubstrate bindingX-ray crystallography

Identifiers

PMID30327430
PMCPMC6302162
OpenAlexW2897269413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.